Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

February 22, 2024

https://www.prnewswire.com/news-releases/karyopharm-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-29-2024-302068088.html

— Conference Call Scheduled for Thursday, February 29, 2024, at 8:00 a.m. ET —

NEWTON, Mass., Feb. 22, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2023 financial results on Thursday, February 29, 2024. Karyopharm’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 29, 2024, to discuss the financial results and other company updates.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.